Position in FHTX
as of Dec 31, 2025
· filed Jan 29, 2026
Position Value
$10,416,556
+$1,128,213 QoQ
Shares Held
1,928,992
+1.6% QoQ
Ownership
3.29%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 12.46215640085599.ToString("F0")%
None 87.53784359914401.ToString("F0")%
Common Shares in FHTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Dec 31, 2025VANGUARD GROUP INC holds $65,710,461,655 across 449 Biotechnology names. FHTX ranks #218 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
24,105,823 | $10,928,615,912 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,075,153 | $7,004,838,343 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
13,553,932 | $5,389,721,058 | |
| 4 | INSM |
INSMED Inc
|
21,076,344 | $3,668,126,907 | |
| 5 | INCY |
Incyte Corp
|
19,911,434 | $1,966,652,333 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
16,719,886 | $1,331,738,919 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
16,440,459 | $1,300,604,709 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
16,862,691 | $1,289,827,232 |
All Filings in FHTX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $10,416,556 | 1,928,992 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $9,288,343 | 1,899,457 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $8,857,962 | 1,884,673 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $6,696,391 | 1,834,628 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $8,258,394 | 1,749,660 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $16,124,723 | 1,731,979 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $6,092,038 | 1,059,485 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $7,397,727 | 1,102,493 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $6,611,977 | 1,025,113 | Shares | Defined | 2024-03-11 | |
| 2023-09-30 | $5,093,395 | 1,018,679 | Shares | Sole | 2023-12-18 | |
| 2023-06-30 | $7,145,155 | 1,014,937 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,336,182 | 1,021,965 | Shares | Sole | 2023-07-14 | |
| 2022-12-31 | $6,494,124 | 1,017,888 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $8,690,870 | 1,012,922 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $13,703,209 | 1,007,589 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $13,109,525 | 860,770 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $19,318,081 | 844,691 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $11,700,043 | 839,917 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $7,295,910 | 683,778 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $5,368,660 | 407,334 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $8,177,949 | 403,451 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||